DK2011796T3 - Neurogenese-inducer eller terapeutisk middel mod neuropati omfattende alkyletherderivat eller salt deraf - Google Patents

Neurogenese-inducer eller terapeutisk middel mod neuropati omfattende alkyletherderivat eller salt deraf

Info

Publication number
DK2011796T3
DK2011796T3 DK07742276.4T DK07742276T DK2011796T3 DK 2011796 T3 DK2011796 T3 DK 2011796T3 DK 07742276 T DK07742276 T DK 07742276T DK 2011796 T3 DK2011796 T3 DK 2011796T3
Authority
DK
Denmark
Prior art keywords
neurogenese
alkyletheric
induces
derivatives
salts
Prior art date
Application number
DK07742276.4T
Other languages
English (en)
Inventor
Noboru Iwakami
Shigeki Marubuchi
Tomohiro Okuda
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK2011796T3 publication Critical patent/DK2011796T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK07742276.4T 2006-04-26 2007-04-24 Neurogenese-inducer eller terapeutisk middel mod neuropati omfattende alkyletherderivat eller salt deraf DK2011796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006122080 2006-04-26
PCT/JP2007/058841 WO2007125913A1 (ja) 2006-04-26 2007-04-24 アルキルエーテル誘導体またはその塩を含有する神経細胞新生誘導剤および精神障害治療剤

Publications (1)

Publication Number Publication Date
DK2011796T3 true DK2011796T3 (da) 2014-10-27

Family

ID=38655439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07742276.4T DK2011796T3 (da) 2006-04-26 2007-04-24 Neurogenese-inducer eller terapeutisk middel mod neuropati omfattende alkyletherderivat eller salt deraf

Country Status (20)

Country Link
US (1) US20090093453A1 (da)
EP (1) EP2011796B1 (da)
JP (2) JP5695293B2 (da)
KR (1) KR101374593B1 (da)
CN (1) CN101432280B (da)
AU (1) AU2007244409B2 (da)
BR (1) BRPI0710239A2 (da)
CA (1) CA2648898C (da)
CY (1) CY1115643T1 (da)
DK (1) DK2011796T3 (da)
ES (1) ES2518371T3 (da)
IL (1) IL194569A (da)
MX (1) MX2008013728A (da)
NO (1) NO342153B1 (da)
NZ (1) NZ571975A (da)
PL (1) PL2011796T3 (da)
PT (1) PT2011796E (da)
SI (1) SI2011796T1 (da)
WO (1) WO2007125913A1 (da)
ZA (1) ZA200808728B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161308A0 (en) 2001-10-19 2004-09-27 Toyama Chemical Co Ltd Alkyl ether derivatives or their salts
SI1514542T1 (sl) 2002-06-14 2012-06-29 Toyama Chemical Co Ltd Farmacevtska sestava, vsebujoäśa takrin ali donepezil za izboljĺ anje moĺ˝ganske funkcije
ES2398934T3 (es) * 2005-03-28 2013-03-22 Toyama Chemical Co., Ltd. Proceso de la producción de1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)acetidin-ol o sales del mismo
DK2048145T3 (da) * 2006-08-04 2011-04-04 Toyama Chemical Co Ltd Forstærker af aktiviteten af proteinkinase C indeholdende alkyletherderivat eller et salt deraf
DK2287160T3 (da) * 2008-05-28 2014-06-10 Toyama Chemical Co Ltd Benzothiophenoxidderivat og salt deraf
CN105555763B (zh) * 2013-09-12 2018-04-17 豪夫迈·罗氏有限公司 吲哚‑甲酰胺衍生物
RU2680247C2 (ru) * 2014-01-31 2019-02-19 Тояма Кемикал Ко., Лтд. Средство, усиливающее эффект реабилитации после нервного повреждения, которое содержит производное простого алкилового эфира или его соль
WO2016199878A1 (ja) * 2015-06-11 2016-12-15 富山化学工業株式会社 シグマ受容体結合剤
BR112018011948B1 (pt) * 2015-12-25 2023-10-03 Fujifilm Toyama Chemical Co., Ltd Comprimido compreendendo 1-(3-(2-(1-benzotiofen-5-il)etoxi)propil) azetidin-3-ol ou sal do mesmo
WO2018124281A1 (ja) * 2016-12-28 2018-07-05 富山化学工業株式会社 外用組成物
BR112019024983A2 (pt) 2017-06-02 2020-06-23 Fujifilm Toyama Chemical Co., Ltd. Agente para reduzir a quantidade de proteína b amiloide
SG11201911512SA (en) 2017-06-02 2020-01-30 Fujifilm Toyama Chemical Co Ltd Agent for preventing or treating brain atrophy
JPWO2018221728A1 (ja) 2017-06-02 2020-04-02 富士フイルム富山化学株式会社 アルツハイマー型認知症予防または治療剤
CA3067455C (en) * 2017-06-02 2021-11-23 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating spinocerebellar ataxia
WO2019088083A1 (ja) 2017-10-30 2019-05-09 富士フイルム富山化学株式会社 エモパミル結合タンパク質結合剤およびその利用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294346B1 (en) 1991-07-08 2001-09-25 Neurospheres Holdings, Ltd. Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
JPH05284992A (ja) * 1992-04-14 1993-11-02 Sagami Chem Res Center 神経成長因子産生促進剤及びその製造法
GB9309749D0 (en) * 1993-05-12 1993-06-23 Boots Co Plc Therapeutic agents
JPH07285912A (ja) * 1994-04-19 1995-10-31 Asahi Chem Ind Co Ltd 新規化合物ａｍ５２２１
JP2733207B2 (ja) * 1995-05-18 1998-03-30 工業技術院長 繊維芽細胞成長因子キメラ蛋白質を含有する医薬組成物
WO1999031056A1 (en) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
IL129178A0 (en) * 1999-03-25 2000-02-17 Yeda Res & Dev Induction of nerve generation
WO2000076957A1 (en) * 1999-06-11 2000-12-21 Toyama Chemical Co., Ltd. N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
GB2367554A (en) * 2000-10-04 2002-04-10 Lilly Co Eli Pharmacologically active amines
US20040030131A1 (en) * 2000-10-04 2004-02-12 Martine Keenan Pharmaceutical compounds
JP4303435B2 (ja) * 2001-02-26 2009-07-29 富山化学工業株式会社 ミトコンドリア機能賦活剤
JP4357802B2 (ja) * 2001-07-05 2009-11-04 武田薬品工業株式会社 ベンゼン環縮合５員複素環式化合物、その製造法および用途
WO2003004485A1 (fr) * 2001-07-05 2003-01-16 Takeda Chemical Industries, Ltd. Composes heterocycles a 5 chainons condenses avec un benzo, leur procede de preparation et leur utilisation
JP4905752B2 (ja) * 2001-07-24 2012-03-28 エスティー・ラボ株式会社 揮発性有機塩素化合物センサ
IL161308A0 (en) * 2001-10-19 2004-09-27 Toyama Chemical Co Ltd Alkyl ether derivatives or their salts
JP4537011B2 (ja) * 2002-03-01 2010-09-01 武田薬品工業株式会社 抗うつ剤
SI1514542T1 (sl) * 2002-06-14 2012-06-29 Toyama Chemical Co Ltd Farmacevtska sestava, vsebujoäśa takrin ali donepezil za izboljĺ anje moĺ˝ganske funkcije
JP2004256428A (ja) * 2003-02-25 2004-09-16 Science Univ Of Tokyo 神経栄養因子様プリン系化合物含有作用剤
PT1614419E (pt) * 2003-04-17 2012-10-22 Toyama Chemical Co Ltd Medicamentos para a prevenção ou o tratamento de doenças do nervo da retina contendo derivados de éter de alquilo ou os seus sais
WO2005032535A1 (ja) * 2003-10-03 2005-04-14 Ono Pharmaceutical Co., Ltd. 神経再生促進剤

Also Published As

Publication number Publication date
CA2648898C (en) 2015-01-20
US20090093453A1 (en) 2009-04-09
KR101374593B1 (ko) 2014-03-17
JP2013177410A (ja) 2013-09-09
JPWO2007125913A1 (ja) 2009-09-10
PL2011796T3 (pl) 2015-03-31
CN101432280A (zh) 2009-05-13
WO2007125913A1 (ja) 2007-11-08
SI2011796T1 (sl) 2015-02-27
EP2011796B1 (en) 2014-10-08
NO342153B1 (no) 2018-04-03
CY1115643T1 (el) 2017-01-04
CN101432280B (zh) 2012-11-21
IL194569A0 (en) 2009-08-03
JP5695293B2 (ja) 2015-04-01
ZA200808728B (en) 2010-01-27
IL194569A (en) 2014-09-30
KR20080111131A (ko) 2008-12-22
CA2648898A1 (en) 2007-11-08
AU2007244409B2 (en) 2011-12-01
NO20084338L (no) 2008-11-19
ES2518371T3 (es) 2014-11-05
MX2008013728A (es) 2009-01-07
EP2011796A1 (en) 2009-01-07
AU2007244409A1 (en) 2007-11-08
PT2011796E (pt) 2014-11-26
BRPI0710239A2 (pt) 2011-08-09
EP2011796A4 (en) 2010-07-07
NZ571975A (en) 2011-04-29

Similar Documents

Publication Publication Date Title
DK2011796T3 (da) Neurogenese-inducer eller terapeutisk middel mod neuropati omfattende alkyletherderivat eller salt deraf
NO2022057I1 (no) Capmatinib or a pharmaceutically acceptable salt thereof
FIC20253005I1 (fi) Seladelpaarin L-lysiinisuola, erityisesti seladelpaari-L-lysiinidihydraatti
NO2025009I1 (no) Oxathiapiprolin or an N-oxide or salt thereof and amisulbrom
FIC20210018I1 (fi) Cenobamat eller ett farmaceutiskt salt därav
FIC20240039I1 (fi) Kapivasertibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan muodossa
NO2018037I1 (no) Simeprevir, eller salt derav, innbefattende natrium-simeprevir
NO2019027I1 (no) kobicistat eller et farmasøytisk akseptabelt salt derav
NO2020038I1 (no) Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
NO2020037I1 (no) alpelisib eller et farmasøytisk akseptabelt salt derav
NO2024053I1 (no) aprocitentan eller et farmasøytisk akseptabelt salt derav
NO2019024I1 (no) Brigatinib eller et farmasøytisk akseptabelt salt derav
NL300885I2 (nl) Irinotecansucrosofaatzout
DK2206707T3 (da) Azolcarboxamidforbindelse eller salt deraf
IL253885A0 (en) Ligands for imaging cardiac innervation
NO2017059I1 (no) ribosiklib eller et farmasøytisk akseptabelt salt derav
NO2016014I2 (no) ceritinib eller farmasøytisk akseptable salter derav
DK2068839T3 (da) Farmaceutiske sammensætninger omfattende nilotinib eller salt deraf
DK2351747T3 (da) Fungicide N-cycloalkylbenzylamidderivater
DK1466912T3 (da) 2-acylaminothiazolderivat eller salt deraf
SI3424932T1 (sl) Boronoftalidi za terapevtsko uporabo
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
EP1973405A4 (en) HYDROXYALKYLARYLAMID DERIVATIVES
DK2035394T3 (da) 2-pyrazincarboxamidderivater